Search

Your search keyword '"Ingster O."' showing total 22 results

Search Constraints

Start Over You searched for: Author "Ingster O." Remove constraint Author: "Ingster O." Search Limiters Full Text Remove constraint Search Limiters: Full Text
22 results on '"Ingster O."'

Search Results

2. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

3. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

4. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

5. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

6. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

7. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

8. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

9. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

10. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

11. Interphase cytogenetic studies of human hepatocellular carcinomas by fluorescentin situ hybridization

12. Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations

13. Breast and ovarian cancer predisposition due to de novo BRCA1and BRCA2mutations

14. Medulloblastomas with ELP1 pathogenic variants: A weakly penetrant syndrome with a restricted spectrum in a limited age window.

15. Blood functional assay for rapid clinical interpretation of germline TP53 variants.

16. Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.

17. Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort.

18. Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations.

19. Germline CDKN2A /P16INK4A mutations contribute to genetic determinism of sarcoma.

20. Evaluation of the colorectal cancer risk conferred by rare UNC5C alleles.

21. A de novo germline MLH1 mutation in a Lynch syndrome patient with discordant immunohistochemical and molecular biology test results.

22. Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.

Catalog

Books, media, physical & digital resources